Swiss Clinical Quality Management Programm (SCQM)

​The SCQM program was founded in 1997 in Zürich as a quality management instrument of the treatment of rheumatoid arthritis. The input of data on disease activity, function, damage, quality of life etc. allows a targeted therapy and makes communication between patient and physician easier. The anonymised data is also used for research.


Published studies (selection)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Finckh A, Möller B, Dudler J, Walker UA, Kyburz D, Gabay C; physicians of the Swiss Clinical Quality Management for Rheumatoid Arthritis; physicians of SCQM-RA. Ann Rheum Dis. 71(10):1680-5, 2012

The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Kyburz D, Gabay C, Michel BA, Finckh A; physicians of SCQM-RA. Rheumatology (Oxford). 50:1106-10, 2011.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C; Arthritis. Ann Rheum Dis. 69:387-93, 2010. 

We use cookies to make our website user-friendly, to continuously improve it and to analyze the traffic of our website. By continuing to browse the site, you are agreeing to our use of cookies. Further information can be found in our privacy policy.